Co-Diagnostics (Co-Diagnostics) Scaled Net Operating Assets

: 0.28 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Co-Diagnostics's operating assets for the quarter that ended in Dec. 2023 was $36.77 Mil. Co-Diagnostics's operating liabilities for the quarter that ended in Dec. 2023 was $6.32 Mil. Co-Diagnostics's Total Assets for the quarter that ended in Sep. 2023 was $108.68 Mil. Therefore, Co-Diagnostics's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was 0.28.

Co-Diagnostics Scaled Net Operating Assets Historical Data

The historical data trend for Co-Diagnostics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Co-Diagnostics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

0.54

8.75

0.63

0.21

0.25

Co-Diagnostics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Scaled Net Operating Assets																0.23	0.30	0.32	0.35	0.28

Competitive Comparison

For the Medical Devices subindustry, Co-Diagnostics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Co-Diagnostics Scaled Net Operating Assets Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Co-Diagnostics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Co-Diagnostics's Scaled Net Operating Assets falls into.

Co-Diagnostics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Co-Diagnostics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(36.773	-	6.317)	/	123.086
=	0.25

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	95.321	-	58.548
=	36.773

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	9.307	-	2.152	-	0.838
=	6.317

Co-Diagnostics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2023 )
=	(Operating Assets (Q: Dec. 2023 )	-	Operating Liabilities (Q: Dec. 2023 ))	/	Total Assets (Q: Sep. 2023 )
=	(36.773	-	6.317)	/	108.682
=	0.28

where

	Operating Assets		(Q: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	95.321	-	58.548
=	36.773

	Operating Liabilities		(Q: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	9.307	-	2.152	-	0.838
=	6.317

Co-Diagnostics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Co-Diagnostics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Co-Diagnostics (Co-Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Co-Diagnostics Inc (NAS:CODX) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

C97:Germany

Address

2401 South Foothill Drive, Salt Lake City, UT, USA, 84109

Website

https://www.codiagnostics.com

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.

Executives

Brian Lee Brown	officer: Chief Financial Officer	5322 W. BRIAR PARK ROAD, HERRIMAN UT 84096
Ted Murphy	director	64 INDUSTRIAL RD., RICHMOND HILL A6 L4C2Y1
Eugene Durenard	director	2401 S. FOOTHILL DRIVE SUITE D, SALT LAKE CITY UT 84109
Dwight H Egan	director, officer: CEO and President	4049 S. HIGHLAND DRIVE, SALT LAKE CITY UT 84124
Richard S Serbin	director	750 LEXINGTON AVENUE, 6TH FLOOR, NEW YORK NY 10022
James B Nelson	director	26 WEST MISSION AVENUE, SUITE 8, SANTA BARBARA CA 93010
Reed L Benson	officer: CFO and Secretary	7050 UNION PARK CENTER, #600, SALT LAKE CITY UT 84047
Edward L. Murphy	director	2401 S. FOOTHILL DRIVE SUITE D, SALT LAKE CITY UT 84109
Brent Satterfield	director, officer: Chief Science Officer	4049 S. HIGHLAND DRIVE, SALT LAKE CITY UT 84124
America 2030 Capital, Llc	10 percent owner	1301 SHILOH RD., NW, SUITE 1231, KENNESAW GA 30144
Edward Borkowski	director	1500 CORPORATE DRIVE, SUITE 400, CANONSBURG PA 15317
Frank J Kiesner	director	4049 S. HIGHLAND DRIVE, SALT LAKE CITY UT 84124
Reagents, Llc	10 percent owner	8160 S. HIGHLAND DR, SANDY UT 84093
Legends Capital Group, Llc	10 percent owner	4049 S. HIGHLAND DRIVE, SALT LAKE CITY UT 84124